(Q45261068)

11 December 2017

title

The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism (English)

1 reference

11 December 2017

1 reference

1 reference

1 reference

1

1 reference

11 December 2017

7

1 reference

11 December 2017

Valeria Rimoldi

2

1 reference

11 December 2017

Tiziana Marrocco

3

1 reference

11 December 2017

Paola Cassoni

4

1 reference

11 December 2017

Giovanni Bussolati

5

1 reference

11 December 2017

Marco Parenti

6

1 reference

11 December 2017

language of work or name

English

0 references

publication date

10 February 2005

1 reference

Journal of Biological Chemistry

11 December 2017

published in

1 reference

11 December 2017

volume

280

1 reference

11 December 2017

issue

16

1 reference

11 December 2017

page(s)

16311-16318

1 reference

Structure and expression of a human oxytocin receptor

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin antagonists: clinical and scientific considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Ligand-selective receptor conformations revisited: the promise and the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

The [35S]GTPγS binding assay: approaches and applications in pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Principles: extending the utility of [35S]GTP gamma S binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

The putative somatostatin antagonist, cyclo-(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr[BZL]), may act as potent antiproliferative agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Design, synthesis and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Molecular basis of ligand binding and receptor activation in the oxytocin and vasopressin receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Molecular modeling of the neurohypophyseal receptor/atosiban complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409945200

21 January 2018

Identifiers

DOI

10.1074/JBC.M409945200

1 reference

11 December 2017

1 reference